Yahoo
NasdaqCM - Nasdaq Real Time Price USD

Acurx Pharmaceuticals, Inc. (ACXP)

1.0600 +0.1143 (+12.09%)
At close: November 6 at 4:00:01 PM EST
1.1300 +0.0700 (+6.60%)
Pre-Market: 5:58:43 AM EST
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements have been upgraded
A new layout with more detail in every statement.
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Cash Flow from Operating Activities, Indirect
-6,183.1940 -6,787.7820 -10,383.4310 -9,800.8850 -7,542.2900
Cash Flow from Financing Activities
10,775.4520 10,637.1690 6,615.9560 8,163.3220 3,695.1950
Cash and Cash Equivalents, End of Period
10,656.3860 7,556.1000 3,706.7130 7,474.1880 9,111.7510
Cash Flow, Supplemental
Free Cash Flow to Firm
-6,189.7520 -6,396.8180 -10,667.5200 -10,811.6580 -8,790.4150
Issuance of Capital Stock
9,415.9480 6,797.1120 6,405.7570 5,944.2500 3,695.1820
Repurchase of Capital Stock
0 -1.0400 0 0 0
12/31/2022 - 6/25/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: